2008 - Fellow of the Royal Society of New Zealand
Fellow of the Academy of Social Sciences, United Kingdom
Peter C. Tyler mainly focuses on Stereochemistry, Purine nucleoside phosphorylase, Transition state analog, Enzyme and Biochemistry. His research integrates issues of Imine, Transferase, Carbohydrate and Oxocarbenium in his study of Stereochemistry. His studies in Purine nucleoside phosphorylase integrate themes in fields like Guanosine, Reaction coordinate and Nucleophile.
He interconnects Binding site, Hydrogen bond and Hypoxanthine Phosphoribosyltransferase in the investigation of issues within Transition state analog. A large part of his Enzyme studies is devoted to Purine. Peter C. Tyler regularly links together related areas like Nucleotide salvage in his Biochemistry studies.
His main research concerns Stereochemistry, Purine nucleoside phosphorylase, Biochemistry, Transition state analog and Enzyme. In his papers, Peter C. Tyler integrates diverse fields, such as Stereochemistry and Transition. His Purine nucleoside phosphorylase study integrates concerns from other disciplines, such as Transferase, Purine metabolism, Inosine, Leaving group and Purine analogue.
His Biochemistry study frequently draws parallels with other fields, such as Nucleotide salvage. The various areas that Peter C. Tyler examines in his Transition state analog study include Hydrolase, Polyamine and Binding site. Enzyme inhibitor is the focus of his Enzyme research.
Peter C. Tyler mostly deals with Stereochemistry, Biochemistry, Enzyme, Crystal structure and S-adenosylhomocysteine nucleosidase. Peter C. Tyler combines subjects such as Purine nucleoside phosphorylase, Molecule, Entropy and Stereoselectivity with his study of Stereochemistry. His Purine nucleoside phosphorylase research incorporates themes from Methylene, Ribitol and Amine gas treating.
His study in Transition state analog and Active site falls under the purview of Enzyme. Peter C. Tyler has researched Transition state analog in several fields, including Antibiotics and Microbiology. His study looks at the relationship between Hypoxanthine and topics such as Phosphoribosyltransferase, which overlap with Inosine, Hypoxanthine salvage, Purine, Nucleotide salvage and Inosine monophosphate.
Peter C. Tyler spends much of his time researching Biochemistry, Hypoxanthine, Phosphoribosyltransferase, Stereochemistry and Enzyme. He undertakes interdisciplinary study in the fields of Biochemistry and Chemical synthesis through his works. The Hypoxanthine study combines topics in areas such as Purine nucleoside phosphorylase, Purine, Hypoxanthine salvage and Inosine.
His Phosphoribosyltransferase research includes themes of Inosine monophosphate, Xanthine phosphoribosyltransferase, Nucleotide salvage and Purine metabolism. His research on Stereochemistry focuses in particular on Total synthesis. His Enzyme research includes elements of HEXA, Sulfation, Glycosylation and Function.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
One-Third-the-Sites Transition-State Inhibitors for Purine Nucleoside Phosphorylase†
Robert W. Miles;Peter C. Tyler;Richard H. Furneaux;Carey K. Bagdassarian.
Biochemistry (1998)
Transition state structure of purine nucleoside phosphorylase and principles of atomic motion in enzymatic catalysis
A Fedorov;W Shi;G Kicska;E Fedorov.
Biochemistry (2001)
Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes.
Greg A. Kicska;Li Long;Heidi Hörig;Craig Fairchild.
Proceedings of the National Academy of Sciences of the United States of America (2001)
Liposomal delivery of antigen to human dendritic cells.
Melissa J. Copland;Margaret A. Baird;Thomas Rades;Judith L. McKenzie.
Vaccine (2003)
The 2.0 Å structure of human hypoxanthine-guanine phosphoribosyltransferase in complex with a transition-state analog inhibitor
Wuxian Shi;Caroline M. Li;Peter C. Tyler;Richard H. Furneaux.
Nature Structural & Molecular Biology (1999)
Achieving the ultimate physiological goal in transition state analogue inhibitors for purine nucleoside phosphorylase.
Andrzej Lewandowicz;Peter C. Tyler;Gary B. Evans;Richard H. Furneaux.
Journal of Biological Chemistry (2003)
Plasmodium falciparum purine nucleoside phosphorylase: crystal structures, immucillin inhibitors, and dual catalytic function.
Wuxian Shi;Li Min Ting;Gregory A. Kicska;Andrzej Lewandowicz.
Journal of Biological Chemistry (2004)
The 2.0 A structure of malarial purine phosphoribosyltransferase in complex with a transition-state analogue inhibitor.
Wuxian Shi;Caroline M. Li;Peter C. Tyler;Richard H. Furneaux.
Biochemistry (1999)
Femtomolar Transition State Analogue Inhibitors of 5′-Methylthioadenosine/S-Adenosylhomocysteine Nucleosidase from Escherichia coli
Vipender Singh;Gary B. Evans;Dirk H. Lenz;Jennifer M. Mason.
Journal of Biological Chemistry (2005)
Targeting a novel Plasmodium falciparum purine recycling pathway with specific immucillins.
Li Min Ting;Wuxian Shi;Andrzej Lewandowicz;Vipender Singh.
Journal of Biological Chemistry (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Albert Einstein College of Medicine
Victoria University of Wellington
Albert Einstein College of Medicine
University of South Florida
MSD (United States)
University of Montreal
University of Copenhagen
Cornell University
University of Liverpool
University of California, San Francisco
Zhejiang University
Kyoto University
Tel Aviv University
University of Toronto
Indian Institute of Technology Madras
Newcastle University
Universiti Putra Malaysia
University of Edinburgh
University of Connecticut
Catholic University of Korea
University of Western Australia
Halliburton (United Kingdom)
Maastricht University
Semmelweis University
University of Wisconsin–Madison
Washington University in St. Louis